AGEING RES REV 润色咨询

AGEING RESEARCH REVIEWS

出版年份：2002 年文章数：1191 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2026-05-08 小丸子冲冲冲 来自湖南省

    请问期刊喜欢脓毒症相关综述吗？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2026-04-07 12382cddm26暂无昵称 来自四川省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：线粒体
    经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。
    整体很顺利，速度超快，感谢编辑，感谢ARR

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2021-05-21 da-xiang

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利
    兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下
    http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2025-03-06 匿名用户

    只有Review Article，Short Review， View Point 三种文章类型

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2023-10-07 snowboy 来自云南省

    投稿命中率:25.0
    经验分享：with editor时间比较长

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2024-03-04 ms4000001279064158 来自广东省

    审稿速度:24.0 | 投稿命中率:75.0
    经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2024-07-01 ms4000001013457283 来自吉林省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：认知;神经退行性疾病
    经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2024-06-26 36192448 来自湖南省

    审稿速度:24.0 | 投稿命中率:50.0
    经验分享：with editor一个月被拒，感觉编辑非常不责任

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2024-01-07 ms6000001711273886 来自山东省

    审稿速度:2.0
    经验分享：无

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2310893, encodeId=0b0c2310893b5, content=请问期刊喜欢脓毒症相关综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/18/96c95649d211527dc83b0368f5219545.jpg, createdBy=c17f2092691, createdName=小丸子冲冲冲, createdTime=Fri May 08 10:40:50 CST 2026, time=2026-05-08, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2306566, encodeId=2d3223065660e, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：线粒体<br>经验分享：一篇衰老相关的综述。初次投稿IJS被秒拒，感谢IJS不杀之恩（贝斯IJS终于on hold了）。改投ARR，一月底投稿，投过去一周就送外审了，02月27日收到返修意见，2个外审，都是小修，给了3周返修时间，忙着改国自然一直没时间返修，赶在3月19日DDL返回去的。再次送审，两个审稿人都同意二次审稿了，一个很快审完，另一个一直没处理。4月6日，编辑直接接收了。<br>整体很顺利，速度超快，感谢编辑，感谢ARR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d78c2414573, createdName=12382cddm26暂无昵称, createdTime=Tue Apr 07 10:21:47 CST 2026, time=2026-04-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=967593, encodeId=ddfa96e5937c, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：近期中了一篇关于衰老基因组的，首次尝试10分+的综述，没想到这么顺利<br>兴奋之余，写了一篇投稿分享，有兴趣的朋友可以读一下<br>http://blog.sciencenet.cn/home.php?mod=space&uid=419182&do=blog&id=1285413, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Fri May 21 20:30:53 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2254867, encodeId=a178225486e99, content=只有Review Article，Short Review， View Point 三种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Mar 06 14:48:18 CST 2025, time=2025-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161347, encodeId=d1ad216134ea4, content=投稿命中率:25.0<br>经验分享：with editor时间比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Sat Oct 07 15:07:56 CST 2023, time=2023-10-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2191052, encodeId=f74d21910521b, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享：太慢了！半年多了还没找到审稿人，每次问就回复我们会尽快保证审稿速度啥的，没啥实际进展。嫌慢的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee278480238, createdName=ms4000001279064158, createdTime=Mon Mar 04 22:04:54 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2212564, encodeId=37962212564d8, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：认知;神经退行性疾病<br>经验分享：3.11投，3.20多号送审的，6.1返修，两个审稿人，3.19修回，6.30接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b869023853, createdName=ms4000001013457283, createdTime=Mon Jul 01 10:19:53 CST 2024, time=2024-07-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2211732, encodeId=eba22211e32b7, content=审稿速度:24.0 | 投稿命中率:50.0<br>经验分享：with editor一个月被拒，感觉编辑非常不责任, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Wed Jun 26 14:47:12 CST 2024, time=2024-06-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2179845, encodeId=423221e984518, content=审稿速度:2.0<br>经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8a8539858, createdName=ms6000001711273886, createdTime=Sun Jan 07 21:49:46 CST 2024, time=2024-01-07, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1248959, encodeId=5e8e124895971, content=with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Wed Sep 14 21:55:23 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2022-09-14 ms3000001949605315

    with editor 9天了，有点慌，一般这么久是会送审嘛，还是会拒掉

    2

    展开2条回复
共81条页码: 1/9页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分